Crossmark

Safety and efficacy of omaveloxolone v/s placebo for the treatment of Friedreich's ataxia in patients aged more than 16 years: a systematic review

Published Online: 2024-12-30

Authors

Umrao, Ankita

Pahuja, Monika

Chatterjee, Nabendu Sekhar
License Information

Text and Data Mining valid from 2024-12-30

Version of Record valid from 2024-12-30
More Information

Article History

Received: 5 June 2024

Accepted: 20 November 2024

First Online: 30 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current